Ferdinando Frigeri

1.9k total citations
60 papers, 1.2k citations indexed

About

Ferdinando Frigeri is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Ferdinando Frigeri has authored 60 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pathology and Forensic Medicine, 28 papers in Genetics and 16 papers in Oncology. Recurrent topics in Ferdinando Frigeri's work include Lymphoma Diagnosis and Treatment (32 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Viral-associated cancers and disorders (8 papers). Ferdinando Frigeri is often cited by papers focused on Lymphoma Diagnosis and Treatment (32 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Viral-associated cancers and disorders (8 papers). Ferdinando Frigeri collaborates with scholars based in Italy, Malaysia and United States. Ferdinando Frigeri's co-authors include Antonio Pinto, Francesco Salvatore, Fabrizio Pane, Bruno Rotoli, Giuseppe Saglio, Gaetano Corazzelli, Luigia Luciano, F. Ferrara, G Meloni and Rosaria De Filippi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal Of Pathology.

In The Last Decade

Ferdinando Frigeri

57 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ferdinando Frigeri Italy	19	483	437	422	339	211	60	1.2k
H Kantarjian United States	16	501 1.0×	288 0.7×	594 1.4×	310 0.9×	310 1.5×	28	1.2k
Francesc Cobo Spain	18	650 1.3×	573 1.3×	352 0.8×	367 1.1×	266 1.3×	38	1.2k
Zhenya Tang United States	20	332 0.7×	280 0.6×	456 1.1×	335 1.0×	375 1.8×	111	1.2k
José María Sayagués Spain	23	231 0.5×	249 0.6×	294 0.7×	292 0.9×	367 1.7×	66	1.3k
Nicola Di Renzo Italy	24	631 1.3×	944 2.2×	531 1.3×	681 2.0×	329 1.6×	98	1.9k
Michele Merli Italy	17	705 1.5×	474 1.1×	286 0.7×	329 1.0×	303 1.4×	64	1.1k
Jamile M. Shammo United States	17	587 1.2×	227 0.5×	874 2.1×	305 0.9×	429 2.0×	79	1.5k
Mirosław Majewski Poland	16	279 0.6×	353 0.8×	308 0.7×	456 1.3×	522 2.5×	28	1.4k
Thomas Melchardt Austria	23	486 1.0×	396 0.9×	247 0.6×	559 1.6×	380 1.8×	93	1.4k
Piero Galieni Italy	26	564 1.2×	700 1.6×	739 1.8×	706 2.1×	487 2.3×	89	1.7k

Countries citing papers authored by Ferdinando Frigeri

Since Specialization

Citations

This map shows the geographic impact of Ferdinando Frigeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferdinando Frigeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferdinando Frigeri more than expected).

Fields of papers citing papers by Ferdinando Frigeri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferdinando Frigeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferdinando Frigeri. The network helps show where Ferdinando Frigeri may publish in the future.

Co-authorship network of co-authors of Ferdinando Frigeri

This figure shows the co-authorship network connecting the top 25 collaborators of Ferdinando Frigeri. A scholar is included among the top collaborators of Ferdinando Frigeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferdinando Frigeri. Ferdinando Frigeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giordano, Claudia, Elena Rossi, Potito Rosario Scalzulli, et al.. (2024). Treatment of Chronic ITP with Avatrombopag: A Multicentric Real-World Experience. Blood. 144(Supplement 1). 5446–5446.

Francia, Raffaele Di, Stefania Crisci, Concetta Cafiero, et al.. (2021). Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers. Cancers. 13(5). 966–966. 70 indexed citations

Francia, Raffaele Di, Stefania Crisci, Ferdinando Frigeri, et al.. (2017). Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted Therapy. Current Cancer Drug Targets. 18(5). 499–511. 12 indexed citations

Brancaccio, Giuseppina, Ferdinando Frigeri, Lavinia Fabeni, et al.. (2017). Treatment of Acute Hepatitis C With Ledipasvir and Sofosbuvir in Patients With Hematological Malignancies Allows Early Re-start of Chemotherapy. Clinical Gastroenterology and Hepatology. 16(6). 977–978. 7 indexed citations

Franco, Renato, Giosuè Scognamiglio, Antonio Luciano, et al.. (2016). PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas. Oncotarget. 7(37). 59158–59172. 13 indexed citations

Corazzelli, Gaetano, Vincenzo Pavone, F. Angrilli, et al.. (2014). A phase 1/2 study of lenalidomide and bendamustine (LEBEN) in chemorefractory Hodgkin lymphoma.. Journal of Clinical Oncology. 32(15_suppl). 8566–8566. 2 indexed citations

Aloj, Luigi, Michela Aurilio, Ferdinando Frigeri, et al.. (2014). Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma. European Journal of Nuclear Medicine and Molecular Imaging. 41(5). 867–877. 25 indexed citations

Montella, Maurizio, Matteo Malvezzi, Maria Grimaldi, et al.. (2013). Mortality Trend for Tumor Correlated Immune System in Hyperendemic Area of HCV Infection in Southern Italy: Joinpoint Analysis. Hepatitis Monthly. 13(8). e12725–e12725. 3 indexed citations

Scholz, Christian W., Antonio Pinto, Werner Linkesch, et al.. (2012). ⁹⁰Yttrium-Ibritumomab-Tiuxetan as First-Line Treatment for Follicular Lymphoma: 30 Months of Follow-Up Data From an International Multicenter Phase II Clinical Trial. Journal of Clinical Oncology. 31(3). 308–313. 79 indexed citations

10.

Aloj, Luigi, Ferdinando Frigeri, Corrado Caracò, et al.. (2012). Feasibility of bremsstrahlung dosimetry for direct dose estimation in patients undergoing treatment with 90Y-ibritumomab tiuxetan. European Journal of Nuclear Medicine and Molecular Imaging. 39(6). 956–966. 2 indexed citations

11.

Corazzelli, Gaetano, Ferdinando Frigeri, Manuela Arcamone, et al.. (2011). Biweekly rituximab, cyclophosphamide, vincristine, non‐pegylated liposome‐encapsulated doxorubicin and prednisone (R‐COMP‐14) in elderly patients with poor‐risk diffuse large B‐cell lymphoma and moderate to high ‘life threat’ impact cardiopathy. British Journal of Haematology. 154(5). 579–589. 41 indexed citations

12.

Laszlò, Daniele, Giovanna Andreola, Luigi Rigacci, et al.. (2010). Rituximab and Subcutaneous 2-Chloro-2′-Deoxyadenosine Combination Treatment for Patients With Waldenström Macroglobulinemia: Clinical and Biologic Results of a Phase II Multicenter Study. Journal of Clinical Oncology. 28(13). 2233–2238. 41 indexed citations

13.

Omodei, Daniela, Dario Acampora, Filippo Russo, et al.. (2009). Expression of the Brain Transcription Factor OTX1 Occurs in a Subset of Normal Germinal-Center B Cells and in Aggressive Non-Hodgkin Lymphoma. American Journal Of Pathology. 175(6). 2609–2617. 22 indexed citations

14.

Rabascio, Cristina, Daniele Laszlò, Giovanna Andreola, et al.. (2009). Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenström's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chloro-2′-deoxyadenosine (2-CdA) and Rituximab. Leukemia Research. 34(4). 454–457. 9 indexed citations

15.

Corazzelli, Gaetano, Gaetana Capobianco, Manuela Arcamone, et al.. (2009). Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma. Cancer Chemotherapy and Pharmacology. 64(5). 907–916. 58 indexed citations

16.

Montella, Maurizio, Anna Crispo, Francesco Izzo, et al.. (2001). HCV and cancer: a case‐control study in a high‐endemic area. Liver International. 21(5). 335–341. 52 indexed citations

17.

Montella, Maurizio, Anna Crispo, Ferdinando Frigeri, et al.. (2001). HCV and tumors correlated with immune system: a case-control study in an area of hyperendemicity. Leukemia Research. 25(9). 775–781. 40 indexed citations

18.

Guadagni, Stefano, et al.. (1999). Chronic lymphocytic leukaemia and neuroendocrine cancer. British Journal of Haematology. 105(4). 989–992. 1 indexed citations

19.

Hauptschein, Robert, Andrey Rzhetsky, Luigi Scotto, et al.. (1998). Analysis of a 69-kb Contiguous Genomic Sequence at a Putative Tumor Suppressor Gene Locus on Human Chromosome 6q27. DNA sequence. 9(4). 189–204. 6 indexed citations

20.

Camera, Andrea, Giovanni Cennamo, Fausto Tranfa, et al.. (1993). Optic Nerve involvement in Acute Lymphoblastic Leukemia. Leukemia & lymphoma. 11(1-2). 153–155. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact